Open Access
Issue
J Extra Corpor Technol
Volume 45, Number 2, June 2013
Page(s) 112 - 115
DOI https://doi.org/10.1051/ject/201345112
Published online 15 June 2013
  1. Blossom DB. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med. 2008;359:2674. [CrossRef] [PubMed] [Google Scholar]
  2. Change in heparin USP monograph [Internet]. FDA; 2009 [updated 10/1/2009]. Available at: www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM112597. Accessed December 1, 2012. [Google Scholar]
  3. Kishimoto TK. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358:2457. [CrossRef] [PubMed] [Google Scholar]
  4. FDA public health alert: Change in heparin USP monograph [Internet]. FDA; 2009 [updated 10/1/2009]. Available at: www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm184502.htm. Accessed December 1, 2012. [Google Scholar]
  5. Smythe MA, Nutescu EA, Wittkowsky AK. Changes in the USP heparin monograph and implications for clinicians. Pharmacotherapy. 2010;30:428–431. [CrossRef] [PubMed] [Google Scholar]
  6. Drug safety podcasts > podcast for healthcare professionals: Follow up to the public health alert about changes to the heparin sodium USP monograph [Internet]. FDA; 2010 [updated 04/15/2010]. Available at: www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm208545.htm. Accessed December 1, 2012. [Google Scholar]
  7. Honchel R, Carraway J, Gopee N, et al. A dose–response study in animals to evaluate the anticoagulant effect of the stage 2 unfractionated heparin USP monograph change. Regul Toxicol Pharmacol. 2011;60:318–322. [CrossRef] [Google Scholar]
  8. Bull BS. Heparin therapy during extracorporeal circulation. II. The use of a dose–response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685. [CrossRef] [Google Scholar]
  9. ACCP newsletter—FDA announces new standards for heparin— October 12, 2009 [Internet]. 2009 Available at: www.chestnet. org/accp/article/fda-announces-new-standards-heparin. Accessed February 23, 2011. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.